Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.47 |
| ▸ | NAAA | Q02083 | 1/20 | 0.47 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28919562 | 0.98 | ALDH1A1 (0.50) | ALDH1A1ATMGPR84NAAAFFAR1 | |
| SCHEMBL3014709 | 0.94 | GPR84 (0.55) | ALDH1A1ATMGPR84NAAAFFAR1 | |
| SCHEMBL15234461 | 0.94 | NAAA (0.55) | ALDH1A1GPR84NAAAFFAR1TSHR | |
| SCHEMBL8847120 | 0.92 | GPR84 (0.59) | ALDH1A1ATMGPR84NAAAFFAR1 | |
| SCHEMBL1683936 | 0.92 | GPR84 (0.59) | ALDH1A1ATMGPR84NAAAFFAR1 | |
| SCHEMBL31430526 | 0.92 | GPR84 (0.59) | ALDH1A1ATMGPR84NAAAFFAR1 | |
| SCHEMBL17345955 | 0.92 | GPR84 (0.59) | ALDH1A1ATMGPR84NAAAFFAR1 | |
| SCHEMBL1683713 | 0.92 | GPR84 (0.59) | ALDH1A1ATMGPR84NAAAFFAR1 | |
| SCHEMBL8379735 | 0.92 | GPR84 (0.59) | ALDH1A1ATMGPR84NAAAFFAR1 | |
| SCHEMBL28284384 | 0.92 | GPR84 (0.59) | ALDH1A1ATMGPR84NAAAFFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102388010-B | Method for producing 1,6-hexanediol and caprolactone | BASF SE | 2015-04-08 | — | — | CN | claimed |
| CN-102388010-A | Method for producing 1,6-hexanediol and caprolactone | BASF SE | 2012-03-21 | — | — | CN | claimed |
| CN-102239131-A | Process for preparing 1, 6-hexanediol | BASF SE | 2011-11-09 | — | — | CN | claimed |
| US-20050069504-A1 | Coating for nail care having antimicrobial properties | BEAURLINE DANIEL J (US) | 2005-03-31 | — | — | US | claimed |
| WO-2003045339-A2 | COATING FOR NAIL CARE HAVING ANTIMICROBIAL PROPERTIES | ALMELL, LTD. (US) | 2003-06-05 | — | — | WO | claimed |
| CN-1089742-C | Process for preparing 1,6-hexane diol and caprolacton | BASF AG (DE) | 2002-08-28 | — | — | CN | claimed |
| CN-1211969-A | Process for preparing 1,6-hexane diol and caprolacton | BASF AG (DE) | 1999-03-24 | — | — | CN | claimed |
| EP-3331491-B1 | POLYMERS DERIVED FROM AMINO-FUNCTIONAL VINYL ALCOHOL ETHERS AND APPLICATIONS THEREOF | ISP INVESTMENTS LLC (US) | 2022-03-23 | — | — | EP | disclosed |
| US-10927197-B2 | Polymers derived from amino-functional vinyl alcohol ethers and applications thereof | ISP INVESTMENTS LLC (US) | 2021-02-23 | — | — | US | disclosed |
| WO-2020230690-A1 | LAMINATED-GLASS INTERMEDIATE FILM AND LAMINATED GLASS | 株式会社クラレ | 2020-11-19 | — | — | WO | disclosed |
| US-10494466-B2 | Polymers polymerized from at least four monomers, and compositions and uses thereof | ISP INVESTMENTS LLC (US) | 2019-12-03 | — | — | US | disclosed |
| US-10407528-B2 | UV-absorbing polymers and formulations thereof | ISP INVESTMENTS LLC (US) | 2019-09-10 | — | — | US | disclosed |
| US-10351523-B2 | UV-absorbing compounds with at least one reactive hydrogen | ISP INVESTMENTS LLC | 2019-07-16 | — | — | US | disclosed |
| US-5302379-A | Nail lacquer primary film forming resin | DOW CORNING CORPORATION (US) | 1994-04-12 | — | — | US | disclosed |
| EP-0507469-A1 | Primer for nail lacquers and method | DOW CORNING CORPORATION (US) | 1992-10-07 | — | — | EP | disclosed |
| US-5153268-A | Nail lacquer primary film forming resin | DOW CORNING CORPORATION (US) | 1992-10-06 | — | — | US | disclosed |
| EP-0502636-A2 | Nail lacquer primary film forming resin | DOW CORNING CORPORATION (US) | 1992-09-09 | — | — | EP | disclosed |
| US-4421881-A | NAIL POLISH | DEL LABORATORIES, INC. | 1983-12-20 | — | — | US | disclosed |
| EP-0061348-A1 | Nitrocellulose lacquer composition containing gelatin and acrylic copolymers | A.H. ROBINS COMPANY, INCORPORATED (US) | 1982-09-29 | — | — | EP | disclosed |
| US-4126675-A | METHYL METHACRYLATE-HEXYL METHACRYLATE COPOLYMER, PLASTICIZER, SOLVENT, FILMING AGENT | L'OREAL (FR) | 1978-11-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10407528-B2 | UV-absorbing polymers and formulations thereof | PUF60, UACA, UMPS | ALDH1A1 511/4885ATM 1962/4885GPR84 4277/4885 |
| US-10927197-B2 | Polymers derived from amino-functional vinyl alcohol ethers and applications thereof | DOT1L, TET3, ALKBH3 | ALDH1A1 228/4885ATM 3545/4885GPR84 1636/4885 |
| US-10494466-B2 | Polymers polymerized from at least four monomers, and compositions and uses thereof | ADSL, MMAB, ACMSD | ALDH1A1 1176/4885ATM 356/4885GPR84 3365/4885 |
| US-10351523-B2 | UV-absorbing compounds with at least one reactive hydrogen | ERCC1, ERCC4, UNG | ALDH1A1 263/4885ATM 1476/4885GPR84 4041/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.